To investigate the structural basis underlying potency and selectivity of a series of novel analogues of thieno[2,3-d]pyrimidin-4-yl hydrazones as cyclin-dependent kinase 4 (CDK4) inhibitors and to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback